(SSRX)

3SBio

Close Price:
13.40

Change:
0.00

% Change:
0.00 %

Date:
10/30/2012

52 Week:
9.26 - 15.33

Prev Close:
13.40

Open:
13.40

Volume:
17,727

90D Avg. Volume:
59,562

10/30/2012 Range:
13.30 - 13.46

Market Cap:
295,872,000

Trailing PE Ratio:
15.76

Shares Out:
22,080,000

EPS:
0.85

Yield:
0.00

Dividend:
0.00

Dividend Date:
-

Quarter End:
6/30/2013

3SBio

Website: www.3sbio.com

Business Summary: 3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China.



,

SSRX Earnings Calendar

Q1:
Dec
31
 -
Mar
30
Q2:
Mar
31
 -
Jun
30
Q3:
Jun
30
 -
Sep
29
Q4:
Sep
30
 -
Dec
30
Period Ending
 
Assets
Current Assets
Cash & Cash Equivalents
Short Term Investments
Net Receivables
Inventory
Other Current Assets
Total Current Assets
Long Term Assets
Property Plant & Equipment
Goodwill
Intangible Assets
Accumulated Amortization
Other Assets
Deferred Long Asset Charges
Total Assets
Liabilities
Current Liabilities
Accounts Payable
Short/Current Long Term Debt
Other Current Liabilities
Total Current Liabilities
Long Term Debt
Other Liabilities
Deferred Long Term Liability Charges
Minority Interest
Negative Goodwill
Total Liabilities
Stockholders' Equity
Misc Stock Options Warrants
Redeemable Preferred Stock
Preferred Stock
Common Stock
Retained Earnings
Treasury Stock
Capital Surplus
Other Stockholder Equity
Total Stockholder Equity
Net Tangible Assets
12/31/2009
 
 
 
$39,852
$0
$12,891
$2,257
$0
$124,891
$1,671
$25,437
$0
$604
$0
$1,475
$230
$154,308
 
 
$5,576
$0
$55
$5,631
$0
$0
$407
$0
$0
$6,038
 
$0
$0
$0
$18
$0
$0
$134,066
($14,737)
$148,270
$147,666
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
YoY
 
 
 
(62.9%)
0.0%
6.3%
98.7%
0.0%
3.3%
(57.3%)
122.0%
0.0%
(21.1%)
0.0%
(42.2%)
101.8%
10.5%
 
 
33.6%
0.0%
(12.7%)
32.9%
0.0%
(100.0%)
(11.9%)
0.0%
0.0%
26.7%
 
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.7%
1.6%
9.9%
10.1%
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
12/31/2008
 
 
 
$107,445
$0
$12,122
$1,136
$0
$120,866
$3,914
$11,459
$0
$766
$0
$2,553
$114
$139,672
 
 
$4,173
$0
$63
$4,236
$0
$69
$462
$0
$0
$4,767
 
$0
$0
$0
$18
$0
$0
$133,144
($14,970)
$134,905
$134,139
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
YoY
 
 
 
(3.8%)
0.0%
30.0%
20.5%
0.0%
(1.1%)
81.3%
69.0%
0.0%
(39.6%)
0.0%
203.9%
(55.1%)
4.7%
 
 
25.2%
0.0%
5.0%
24.8%
0.0%
(40.5%)
(4.3%)
(100.0%)
0.0%
17.2%
 
0.0%
0.0%
0.0%
5.9%
0.0%
0.0%
5.9%
(125.9%)
4.3%
4.7%
  
 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
  
  
  
 
  
  
  
  
  
  
  
  
  
  
Period Ending
Net Income
Operating Activities
Depreciation
Adjustments To Net Income
Changes In Accounts Receivables
Changes In Liabilities
Changes In Inventories
Changes In Other Operating Activities
Total from Operating Activities
Investing Activities
Capital Expenditures
Investments
Other Investing Activities
Total from Investing Activities
Financing Activities
Dividends Paid
Sale Purchase of Stock
Net Borrowings
Other Financing Activites
Total from Financing Activities
Effect of Exchange Rate Changes
Change in Cash and Cash Equivalents
12/31/2009
$12,221
 
$1,133
$908
($1,548)
$1,407
($1,122)
($16)
$12,983
 
($13,754)
$618
($27,206)
($38,980)
 
$0
$19
$0
$0
$19
$128
($25,849)
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
YoY
110.9%
 
37.0%
(77.1%)
43.1%
140.5%
(783.5%)
(103.0%)
46.5%
 
(170.6%)
111.5%
37.6%
27.9%
 
0.0%
100.9%
0.0%
0.0%
100.9%
101.8%
52.6%
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
12/31/2008
$5,795
 
$827
$3,967
($2,722)
$585
($127)
$538
$8,863
 
($5,082)
($5,382)
($43,606)
($54,070)
 
$0
($2,120)
$0
$0
($2,120)
($7,168)
($54,495)
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
YoY
(48.1%)
 
41.1%
1,474.2%
(11.7%)
(8.7%)
(151.4%)
151.9%
(6.0%)
 
(217.0%)
(150.3%)
(3,391.3%)
(981.0%)
 
0.0%
(101.8%)
100.0%
0.0%
(101.9%)
(8.1%)
(150.6%)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Period Ending
Total Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Research Development
Selling General & Administrative
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss
Income from Continuing Operations
Total Other Income/Expenses Net
Earnings Before Interest And Taxes
Interest Expense
Income Before Tax
Income Tax Expense
Minority Interest
Net Income From Continuing Ops
 
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares
12/31/2009
$46,422
$3,696
$42,725
 
$2,846
$27,519
$0
$0
$0
$12,360
 
$1,580
$13,940
$0
$13,940
$1,719
$0
$12,221
 
 
$0
$0
$0
$0
$12,221
$0
$12,221
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
YoY
30.2%
16.0%
31.6%
 
(11.3%)
26.3%
0.0%
(100.0%)
0.0%
76.5%
 
278.0%
87.8%
0.0%
87.8%
0.7%
(100.0%)
110.9%
 
 
0.0%
0.0%
0.0%
0.0%
110.9%
0.0%
110.9%
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
12/31/2008
$35,653
$3,187
$32,466
 
$3,208
$21,792
$0
$462
$0
$7,004
 
$418
$7,422
$0
$7,422
$1,707
$80
$5,795
 
 
$0
$0
$0
$0
$5,795
$0
$5,795
  
  
  
  
 
  
  
  
  
  
  
 
  
  
  
  
  
  
  
 
 
  
  
  
  
  
  
  
YoY
44.3%
33.4%
45.5%
 
101.1%
55.0%
0.0%
0.0%
0.0%
5.2%
 
(91.8%)
(36.9%)
(100.0%)
(36.3%)
264.0%
900.0%
(48.1%)
 
 
0.0%
0.0%
0.0%
0.0%
(48.1%)
0.0%
(48.1%)